ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

78 links0 made here, not in the record122 judgments2 judges (the rules as one: Rule based)1 record change seen
Claude Opus 5.5Rule basedRecord updated on ClinicalTrials.govReplaced, or read an older version
Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT03878524Serial Measurements ofMolecular and ArchitecturalResponses to Therapy(SMMART) PRIME TrialOHSU Knight Cancer InstitutePhase 1 · terminatedRECORDThe record itselfVersions seen nightly since Sep 25, 2…›Nov 8 · ClinicalTrials.gov record · MeSH filing re-derivedMeSH filing re-derivedCONDITIONSLeukemia, Myeloid, Accelera…The registry's MeSH filing›No judgment recorded. Shown as the registry files it.AnemiaThe registry's MeSH filing›As of now · Rule based · Main conditionMain conditionLeukemia, Myeloid, Chronic,…The registry's MeSH filing›No judgment recorded. Shown as the registry files it.Blast CrisisThe registry's MeSH filing›No judgment recorded. Shown as the registry files it.Leukemia, Myeloid, Chronic-…The registry's MeSH filing›No judgment recorded. Shown as the registry files it.Breast NeoplasmsThe registry's MeSH filing›No judgment recorded. Shown as the registry files it.Neoplasm MetastasisThe registry's MeSH filing›No judgment recorded. Shown as the registry files it.ThrombocytosisThe registry's MeSH filing›No judgment recorded. Shown as the registry files it.Myeloproliferative DisordersThe registry's MeSH filing›No judgment recorded. Shown as the registry files it.Primary MyelofibrosisThe registry's MeSH filing›No judgment recorded. Shown as the registry files it.Precursor Cell Lymphoblasti…The registry's MeSH filing›No judgment recorded. Shown as the registry files it.Leukemia, Myeloid, AcuteThe registry's MeSH filing›No judgment recorded. Shown as the registry files it.Leukemia, Lymphocytic, Chro…The registry's MeSH filing›No judgment recorded. Shown as the registry files it.Leukemia, Myelogenous, Chro…The registry's MeSH filing›No judgment recorded. Shown as the registry files it.Hematologic NeoplasmsThe registry's MeSH filing›No judgment recorded. Shown as the registry files it.Hodgkin DiseaseThe registry's MeSH filing›No judgment recorded. Shown as the registry files it.Myelodysplastic SyndromesThe registry's MeSH filing›No judgment recorded. Shown as the registry files it.Myelodysplastic-Myeloprolif…The registry's MeSH filing›No judgment recorded. Shown as the registry files it.Lymphoma, Non-HodgkinThe registry's MeSH filing›No judgment recorded. Shown as the registry files it.Multiple MyelomaThe registry's MeSH filing›No judgment recorded. Shown as the registry files it.Leukemia, Myelomonocytic, C…The registry's MeSH filing›No judgment recorded. Shown as the registry files it.Pancreatic NeoplasmsThe registry's MeSH filing›No judgment recorded. Shown as the registry files it.Prostatic NeoplasmsThe registry's MeSH filing›No judgment recorded. Shown as the registry files it.DRUGSAbemaciclibIntervention entry›Nov 1 · Claude Opus 5.5 · BackgroundNov 10 · Claude Opus 5.5 · Background · optionNov 18 · Rule based · TestedBackground · optionAbirateroneIntervention entry›Nov 1 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · TestedBackgroundAfatinibIntervention entry›Nov 1 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · TestedBackgroundBevacizumabIntervention entry›Nov 1 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · TestedBackgroundBicalutamideIntervention entry›Nov 1 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · TestedBackgroundBortezomibIntervention entry›Nov 1 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · TestedBackgroundCabazitaxelIntervention entry›Nov 1 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · TestedBackgroundCabozantinibIntervention entry›Nov 1 · Claude Opus 5.5 · BackgroundNov 10 · Claude Opus 5.5 · Background · optionNov 18 · Rule based · TestedBackground · optionCapecitabineIntervention entry›Nov 1 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · TestedBackgroundCarboplatinIntervention entry›Nov 1 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · TestedBackgroundCelecoxibIntervention entry›Nov 1 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · TestedBackgroundCobimetinibIntervention entry›Nov 1 · Claude Opus 5.5 · BackgroundNov 10 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedCopanlisibIntervention entry›Nov 1 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · TestedBackgroundDabrafenibIntervention entry›Nov 1 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · TestedBackgroundDacomitinibIntervention entry›Nov 1 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · TestedBackgroundDarolutamideIntervention entry›Nov 1 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · TestedBackgroundDasatinibIntervention entry›Nov 1 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · TestedBackgroundDoxorubicinIntervention entry›Nov 1 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · TestedBackgroundDurvalumabIntervention entry›Nov 1 · Claude Opus 5.5 · BackgroundNov 10 · Claude Opus 5.5 · Background · optionNov 18 · Rule based · TestedBackground · optionEnasidenibIntervention entry›Nov 1 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · TestedBackgroundEntrectinibIntervention entry›Nov 1 · Claude Opus 5.5 · BackgroundNov 10 · Claude Opus 5.5 · Background · optionNov 18 · Rule based · TestedBackground · optionEnzalutamideIntervention entry›Nov 1 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · TestedBackgroundErlotinibIntervention entry›Nov 1 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · TestedBackgroundEverolimusIntervention entry›Nov 1 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · TestedBackgroundFluorouracilIntervention entry›Nov 1 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · TestedBackgroundIdelalisibIntervention entry›Nov 1 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · TestedBackgroundImatinibIntervention entry›Nov 1 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · TestedBackgroundIpilimumabIntervention entry›Nov 1 · Claude Opus 5.5 · BackgroundNov 10 · Claude Opus 5.5 · Background · optionNov 18 · Rule based · TestedBackground · optionLenvatinibIntervention entry›Nov 1 · Claude Opus 5.5 · BackgroundNov 2 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · TestedBackgroundLeucovorinIntervention entry›Nov 1 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · TestedBackgroundLorlatinibIntervention entry›Nov 1 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · TestedBackgroundLosartanIntervention entry›Nov 1 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · TestedBackgroundAlbumin-Bound PaclitaxelEntry “Nab-paclitaxel”, read by our n…›Nov 1 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · TestedBackgroundNeratinibIntervention entry›Nov 1 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · TestedBackgroundNivolumabIntervention entry›Nov 1 · Claude Opus 5.5 · BackgroundNov 10 · Claude Opus 5.5 · Background · optionNov 18 · Rule based · TestedBackground · optionOlaparibIntervention entry›Nov 1 · Claude Opus 5.5 · BackgroundNov 10 · Claude Opus 5.5 · Background · optionNov 18 · Rule based · TestedBackground · optionOxaliplatinIntervention entry›Nov 1 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · TestedBackgroundPalbociclibIntervention entry›Nov 1 · Claude Opus 5.5 · BackgroundNov 10 · Claude Opus 5.5 · Background · optionNov 18 · Rule based · TestedBackground · optionPanobinostatIntervention entry›Nov 1 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · TestedBackgroundPembrolizumabIntervention entry›Nov 1 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · TestedBackgroundPertuzumabIntervention entry›Nov 1 · Claude Opus 5.5 · BackgroundNov 10 · Claude Opus 5.5 · Background · optionNov 18 · Rule based · TestedBackground · optionPonatinibIntervention entry›Nov 1 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · TestedBackgroundRegorafenibIntervention entry›Nov 1 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · TestedBackgroundRuxolitinibIntervention entry›Nov 1 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · TestedBackgroundSirolimusIntervention entry›Nov 1 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · TestedBackgroundSorafenibIntervention entry›Nov 1 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · TestedBackgroundSunitinibIntervention entry›Nov 1 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · TestedBackgroundTrametinibIntervention entry›Nov 1 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · TestedBackgroundAdo-Trastuzumab EmtansineEntry “Trastuzumab Emtansine”, read b…›Nov 1 · Claude Opus 5.5 · BackgroundNov 10 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedTretinoinIntervention entry›Nov 1 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · TestedBackgroundVemurafenibIntervention entry›Nov 1 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · TestedBackgroundVenetoclaxIntervention entry›Nov 1 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · TestedBackgroundHhAntag691Entry “Vismodegib”, read by our name …›Nov 1 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · TestedBackgroundVorinostatIntervention entry›Nov 1 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · TestedBackgroundTrastuzumabIntervention entry›Nov 10 · Claude Opus 5.5 · Not givenNot given

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

Abemaciclib

From the registry record3 judgments on this link
Role in the study, from the registry to what was judged
RegistryEntry “Abemaciclib”the record gives no role
→judged=agrees→changed
How the 3 judgments split67%of judgments with a known value say Background · option
Background · 2
Tested · 1

All judgments on this study

WhenLinkJudgeDecisionState
Nov 1AbemaciclibClaude Opus 5.5BackgroundReplaced
Nov 1AbirateroneClaude Opus 5.5BackgroundCurrent
Nov 1AfatinibClaude Opus 5.5BackgroundCurrent
Nov 1BevacizumabClaude Opus 5.5BackgroundCurrent
Nov 1BicalutamideClaude Opus 5.5BackgroundCurrent
Nov 1BortezomibClaude Opus 5.5BackgroundCurrent
Nov 1CabazitaxelClaude Opus 5.5BackgroundCurrent
Nov 1CabozantinibClaude Opus 5.5BackgroundReplaced
Nov 1CapecitabineClaude Opus 5.5BackgroundCurrent
Nov 1CarboplatinClaude Opus 5.5BackgroundCurrent
Nov 1CelecoxibClaude Opus 5.5BackgroundCurrent
Nov 1CobimetinibClaude Opus 5.5BackgroundReplaced
Nov 1CopanlisibClaude Opus 5.5BackgroundCurrent
Nov 1DabrafenibClaude Opus 5.5BackgroundCurrent
Nov 1DacomitinibClaude Opus 5.5BackgroundCurrent
Nov 1DarolutamideClaude Opus 5.5BackgroundCurrent
Nov 1DasatinibClaude Opus 5.5BackgroundCurrent
Nov 1DoxorubicinClaude Opus 5.5BackgroundCurrent
Nov 1DurvalumabClaude Opus 5.5BackgroundReplaced
Nov 1EnasidenibClaude Opus 5.5BackgroundCurrent
Nov 1EntrectinibClaude Opus 5.5BackgroundReplaced
Nov 1EnzalutamideClaude Opus 5.5BackgroundCurrent
Nov 1ErlotinibClaude Opus 5.5BackgroundCurrent
Nov 1EverolimusClaude Opus 5.5BackgroundCurrent
Nov 1FluorouracilClaude Opus 5.5BackgroundCurrent
Nov 1IdelalisibClaude Opus 5.5BackgroundCurrent
Nov 1ImatinibClaude Opus 5.5BackgroundCurrent
Nov 1IpilimumabClaude Opus 5.5BackgroundReplaced
Nov 1LenvatinibClaude Opus 5.5BackgroundReplaced
Nov 1LeucovorinClaude Opus 5.5BackgroundCurrent
Nov 1LorlatinibClaude Opus 5.5BackgroundCurrent
Nov 1LosartanClaude Opus 5.5BackgroundCurrent
Nov 1Albumin-Bound PaclitaxelClaude Opus 5.5BackgroundCurrent
Nov 1NeratinibClaude Opus 5.5BackgroundCurrent
Nov 1NivolumabClaude Opus 5.5BackgroundReplaced
Nov 1OlaparibClaude Opus 5.5BackgroundReplaced
Nov 1OxaliplatinClaude Opus 5.5BackgroundCurrent
Nov 1PalbociclibClaude Opus 5.5BackgroundReplaced
Nov 1PanobinostatClaude Opus 5.5BackgroundCurrent
Nov 1PembrolizumabClaude Opus 5.5BackgroundCurrent
Nov 1PertuzumabClaude Opus 5.5BackgroundReplaced
Nov 1PonatinibClaude Opus 5.5BackgroundCurrent
Nov 1RegorafenibClaude Opus 5.5BackgroundCurrent
Nov 1RuxolitinibClaude Opus 5.5BackgroundCurrent
Nov 1SirolimusClaude Opus 5.5BackgroundCurrent
Nov 1SorafenibClaude Opus 5.5BackgroundCurrent
Nov 1SunitinibClaude Opus 5.5BackgroundCurrent
Nov 1TrametinibClaude Opus 5.5BackgroundCurrent
Nov 1Ado-Trastuzumab EmtansineClaude Opus 5.5BackgroundReplaced
Nov 1TretinoinClaude Opus 5.5BackgroundCurrent
Nov 1VemurafenibClaude Opus 5.5BackgroundCurrent
Nov 1VenetoclaxClaude Opus 5.5BackgroundCurrent
Nov 1HhAntag691Claude Opus 5.5BackgroundCurrent
Nov 1VorinostatClaude Opus 5.5BackgroundCurrent
Nov 2LenvatinibClaude Opus 5.5BackgroundCurrent
Nov 8The record itselfClinicalTrials.gov recordMeSH filing re-derivedRecord change
Nov 10AbemaciclibClaude Opus 5.5Background · optionCurrent
Nov 10CabozantinibClaude Opus 5.5Background · optionCurrent
Nov 10CobimetinibClaude Opus 5.5TestedCurrent
Nov 10DurvalumabClaude Opus 5.5Background · optionCurrent
Nov 10IpilimumabClaude Opus 5.5Background · optionCurrent
Nov 10NivolumabClaude Opus 5.5Background · optionCurrent
Nov 10OlaparibClaude Opus 5.5Background · optionCurrent
Nov 10PalbociclibClaude Opus 5.5Background · optionCurrent
Nov 10PertuzumabClaude Opus 5.5Background · optionCurrent
Nov 10TrastuzumabClaude Opus 5.5Not givenCurrent
Nov 10EntrectinibClaude Opus 5.5Background · optionCurrent
Nov 10Ado-Trastuzumab EmtansineClaude Opus 5.5TestedCurrent
Nov 18AbemaciclibRule based · role ruleTestedOverridden
Nov 18AbirateroneRule based · role ruleTestedOverridden
Nov 18AfatinibRule based · role ruleTestedOverridden
Nov 18BevacizumabRule based · role ruleTestedOverridden
Nov 18BicalutamideRule based · role ruleTestedOverridden
Nov 18BortezomibRule based · role ruleTestedOverridden
Nov 18CabazitaxelRule based · role ruleTestedOverridden
Nov 18CabozantinibRule based · role ruleTestedOverridden
Nov 18CapecitabineRule based · role ruleTestedOverridden
Nov 18CarboplatinRule based · role ruleTestedOverridden
Nov 18CelecoxibRule based · role ruleTestedOverridden
Nov 18CobimetinibRule based · role ruleTestedAgrees
Nov 18CopanlisibRule based · role ruleTestedOverridden
Nov 18DabrafenibRule based · role ruleTestedOverridden
Nov 18DacomitinibRule based · role ruleTestedOverridden
Nov 18DarolutamideRule based · role ruleTestedOverridden
Nov 18DasatinibRule based · role ruleTestedOverridden
Nov 18DoxorubicinRule based · role ruleTestedOverridden
Nov 18DurvalumabRule based · role ruleTestedOverridden
Nov 18EnasidenibRule based · role ruleTestedOverridden
Nov 18EntrectinibRule based · role ruleTestedOverridden
Nov 18EnzalutamideRule based · role ruleTestedOverridden
Nov 18ErlotinibRule based · role ruleTestedOverridden
Nov 18EverolimusRule based · role ruleTestedOverridden
Nov 18FluorouracilRule based · role ruleTestedOverridden
Nov 18IdelalisibRule based · role ruleTestedOverridden
Nov 18ImatinibRule based · role ruleTestedOverridden
Nov 18IpilimumabRule based · role ruleTestedOverridden
Nov 18LenvatinibRule based · role ruleTestedOverridden
Nov 18LeucovorinRule based · role ruleTestedOverridden
Nov 18LorlatinibRule based · role ruleTestedOverridden
Nov 18LosartanRule based · role ruleTestedOverridden
Nov 18Albumin-Bound PaclitaxelRule based · role ruleTestedOverridden
Nov 18NeratinibRule based · role ruleTestedOverridden
Nov 18NivolumabRule based · role ruleTestedOverridden
Nov 18OlaparibRule based · role ruleTestedOverridden
Nov 18OxaliplatinRule based · role ruleTestedOverridden
Nov 18PalbociclibRule based · role ruleTestedOverridden
Nov 18PanobinostatRule based · role ruleTestedOverridden
Nov 18PembrolizumabRule based · role ruleTestedOverridden
Nov 18PertuzumabRule based · role ruleTestedOverridden
Nov 18PonatinibRule based · role ruleTestedOverridden
Nov 18RegorafenibRule based · role ruleTestedOverridden
Nov 18RuxolitinibRule based · role ruleTestedOverridden
Nov 18SirolimusRule based · role ruleTestedOverridden
Nov 18SorafenibRule based · role ruleTestedOverridden
Nov 18SunitinibRule based · role ruleTestedOverridden
Nov 18TrametinibRule based · role ruleTestedOverridden
Nov 18Ado-Trastuzumab EmtansineRule based · role ruleTestedAgrees
Nov 18TretinoinRule based · role ruleTestedOverridden
Nov 18VemurafenibRule based · role ruleTestedOverridden
Nov 18VenetoclaxRule based · role ruleTestedOverridden
Nov 18HhAntag691Rule based · role ruleTestedOverridden
Nov 18VorinostatRule based · role ruleTestedOverridden
As of nowAnemiaRule based · main-condition ruleMain conditionCurrent

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

Which drugs a study tests

Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.

Where the whole record has been read, that reading's answer replaces the rule's.

What a study is mainly about

Starts from the first condition ClinicalTrials.gov files the study under. It moves to a narrower one only when the study's own title or listed conditions name it, and sets aside terms the registry often files by mistake. A study open to many cancers is not placed under one of them unless its title names it.

Checked against studies judged one by one; the study page says when it differs from the registry.